Cargando…
Correction: PLK1/vimentin signaling facilitates immune escape by recruiting Smad2/3 to PD-L1 promoter in metastatic lung adenocarcinoma
Autores principales: | Jang, Hay-Ran, Shin, Sol-Bi, Kim, Chang-Hyeon, Won, Jae-Yeon, Xu, Rong, Kim, Da-Eun, Yim, Hyungshin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525641/ https://www.ncbi.nlm.nih.gov/pubmed/34404920 http://dx.doi.org/10.1038/s41418-021-00842-8 |
Ejemplares similares
-
PLK1/vimentin signaling facilitates immune escape by recruiting Smad2/3 to PD-L1 promoter in metastatic lung adenocarcinoma
por: Jang, Hay-Ran, et al.
Publicado: (2021) -
Combination of Inhibitors of USP7 and PLK1 has a Strong Synergism against Paclitaxel Resistance
por: Shin, Sol-Bi, et al.
Publicado: (2020) -
Active PLK1-driven metastasis is amplified by TGF-β signaling that forms a positive feedback loop in non-small cell lung cancer
por: Shin, Sol-Bi, et al.
Publicado: (2019) -
Correction: Active PLK1-driven metastasis is amplified by TGF-β signaling that forms a positive feedback loop in non-small cell lung cancer
por: Shin, Sol-Bi, et al.
Publicado: (2019) -
Cotargeting Plk1 and androgen receptor enhances the therapeutic sensitivity of paclitaxel-resistant prostate cancer
por: Shin, Sol-Bi, et al.
Publicado: (2019)